CAMBRIDGE, Mass., Jan. 27, 2026 /PRNewswire/ -- Insilico Medicine, a clinical-stage biotechnology company powered by generative AI, and Qilu Pharmaceutical Group, a major comprehensive modern ...
Viking Therapeutics, Inc. (NASDAQ:VKTX) is one of the best US stocks to buy under $50. On January 12, Viking Therapeutics, ...
GlobalData on MSN
FDA and EMA release collaborative AI framework for drug development
The joint guidance was created to ensure drug developers employ best practices when using AI.
HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, today announced a translational preclinical strategy, HKEY-AIRxTM1.0 designed to address one of the most persis ...
Find out how NAMs are influencing safety assessments and decision-making in the pharmaceutical industry ahead of 2026.
A new analysis of drug trials used to approve medicines in the United States shows how far modern medicine still has to go to ...
In Darwinian terms, survival isn’t a matter of being the biggest, the fastest, or the strongest of the species, but instead of adaptability.
The startup has partnered with Eli Lilly and enjoys the backing of some of Silicon Valley's most influential VCs.
The collaboration marks a turning point in AI-driven drug design and trial forecasting, de-risking the drug development ...
Developing high-quality, safe, and effective drugs is a complex process that requires varied scientific skills and stringent regulatory assessments. Drug development is a process that spans many years ...
HKeyBio, a preclinical CRO focused on autoimmune and allergic disease drug development, announced HKEY-AIRx1.0, a translational preclinical ...
The inflation-adjusted cost of developing a new drug now doubles roughly every nine years. To reverse this trend, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results